These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26869415)

  • 1. No Touching! Abrasion of Adsorbed Protein Is the Root Cause of Subvisible Particle Formation During Stirring.
    Sediq AS; van Duijvenvoorde RB; Jiskoot W; Nejadnik MR
    J Pharm Sci; 2016 Feb; 105(2):519-529. PubMed ID: 26869415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.
    Ghazvini S; Kalonia C; Volkin DB; Dhar P
    J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of stirring-induced microparticle formation in monoclonal antibody solutions.
    Ishikawa T; Kobayashi N; Osawa C; Sawa E; Wakamatsu K
    Biol Pharm Bull; 2010; 33(6):1043-6. PubMed ID: 20522974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and analysis of aggregates in a liquid IgG1-antibody formulation.
    Mahler HC; Müller R; Friess W; Delille A; Matheus S
    Eur J Pharm Biopharm; 2005 Apr; 59(3):407-17. PubMed ID: 15760721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.
    Barnard JG; Singh S; Randolph TW; Carpenter JF
    J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelation of a monoclonal antibody at the silicone oil-water interface and subsequent rupture of the interfacial gel results in aggregation and particle formation.
    Mehta SB; Lewus R; Bee JS; Randolph TW; Carpenter JF
    J Pharm Sci; 2015 Apr; 104(4):1282-90. PubMed ID: 25639229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution.
    Nayak A; Colandene J; Bradford V; Perkins M
    J Pharm Sci; 2011 Oct; 100(10):4198-204. PubMed ID: 21698601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.
    Telikepalli SN; Kumru OS; Kalonia C; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2014 Mar; 103(3):796-809. PubMed ID: 24452866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Effect of Cavitation and Agitation on Protein Aggregation.
    Torisu T; Maruno T; Hamaji Y; Ohkubo T; Uchiyama S
    J Pharm Sci; 2017 Feb; 106(2):521-529. PubMed ID: 27887723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.
    Kumru OS; Liu J; Ji JA; Cheng W; Wang YJ; Wang T; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Oct; 101(10):3636-50. PubMed ID: 22733600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.
    Nishi H; Mathäs R; Fürst R; Winter G
    J Pharm Sci; 2014 Jan; 103(1):90-9. PubMed ID: 24218205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes.
    Gerhardt A; Mcumber AC; Nguyen BH; Lewus R; Schwartz DK; Carpenter JF; Randolph TW
    J Pharm Sci; 2015 Dec; 104(12):4056-4064. PubMed ID: 26413998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting.
    Telikepalli S; Shinogle HE; Thapa PS; Kim JH; Deshpande M; Jawa V; Middaugh CR; Narhi LO; Joubert MK; Volkin DB
    J Pharm Sci; 2015 May; 104(5):1575-91. PubMed ID: 25753756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of stirring material on formation of submicron and subvisible aggregates in mAbs by quantitative laser diffraction, dynamic light scattering and background membrane imaging.
    Tathe U; Khopkar S; Rasam P; Kancherla A; Dandekar P; Jain R
    Int J Pharm; 2024 Jul; 660():124321. PubMed ID: 38857661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albinterferon α2b adsorption to silicone oil-water interfaces: effects on protein conformation, aggregation, and subvisible particle formation.
    Basu P; Blake-Haskins AW; O'Berry KB; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Feb; 103(2):427-36. PubMed ID: 24382812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shaken, not stirred: mechanical stress testing of an IgG1 antibody.
    Kiese S; Papppenberger A; Friess W; Mahler HC
    J Pharm Sci; 2008 Oct; 97(10):4347-66. PubMed ID: 18240293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microparticles and Nanoparticles Delivered in Intravenous Saline and in an Intravenous Solution of a Therapeutic Antibody Product.
    Pardeshi NN; Qi W; Dahl K; Caplan L; Carpenter JF
    J Pharm Sci; 2017 Feb; 106(2):511-520. PubMed ID: 27832839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Evaluation of Nanoparticle Tracking Analysis (NanoSight) for Characterization of Proteinaceous Submicron Particles.
    Tian X; Nejadnik MR; Baunsgaard D; Henriksen A; Rischel C; Jiskoot W
    J Pharm Sci; 2016 Nov; 105(11):3366-3375. PubMed ID: 27663383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.